<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Pro-Epanutin; Fosphenytoin" /><meta name="IX" content="Pro-Epanutin; Fosphenytoin" /><title>Pro-Epanutin®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3034-pro-epanutin.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3034-pro-epanutin.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3034-pro-epanutin.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP2092-central-nervous-system.htm">4 Central nervous system</a> &gt; <a href="PHP2897-antiepileptic-drugs.htm">4.8 Antiepileptic drugs</a> &gt; <a href="PHP3022-drugs-used-in-status-epilepticus.htm">4.8.2 Drugs used in status epilepticus</a> &gt; <a href="PHP3033-fosphenytoin-sodium.htm">FOSPHENYTOIN SODIUM</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3029-diazepam.htm" title="Previous: DIAZEPAM">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3035-lorazepam.htm" title="Next: LORAZEPAM">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a301020.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin Sodium</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Central Nervous System Agents 28:00 &gt; Anticonvulsants 28:12 &gt; Hydantoins 28:12.12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/22878-n.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Fosphenytoin</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: F &gt; Interactions of Fosphenytoin</p></div></li></ul><ul><li><h3>British National Formulary (3)</h3></li><li><a href="PHP3022-drugs-used-in-status-epilepticus.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">4.8.2 Drugs used in status epilepticus</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs</p></div></li><li><a href="PHP3033-fosphenytoin-sodium.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">FOSPHENYTOIN SODIUM</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptic drugs &gt; 4.8.2 Drugs used in status epilepticus</p></div></li><li><a href="PHP9390-fosphenytoin-sodium.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin Sodium</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; Appendix 4 Intravenous additives &gt; Use of table &gt; Table of drugs given by intravenous infusion</p></div></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12481-phenytoin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Phenytoin</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.1 Control of the epilepsies</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12544-fosphenytoin-sodium.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">FOSPHENYTOIN SODIUM</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.2 Drugs used in status epilepticus</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12545-pro-epanutin.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pro-Epanutin®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 4 Central nervous system &gt; 4.8 Antiepileptics &gt; 4.8.2 Drugs used in status epilepticus &gt; FOSPHENYTOIN SODIUM</p></div></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0772.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; F</p></div></li></ul><ul><li><h3>Handbook on Injectable Drugs</h3></li><li><a href="http://www.medicinescomplete.com/mc/hid/2010/a599005.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin Sodium</a><div class="breadcrumb"><p><strong>Handbook on Injectable Drugs</strong> &gt; Monographs &gt; F</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0006s0243.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin Sodium</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; F</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/f12-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin sodium</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; F</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/17705-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin Sodium</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiepileptics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04258.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; F &gt; FO</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/c10-sec1-003.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Prodrugs of Alcohols and Phenols</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 1: The Science of Pharmacy &gt; Section 2: Pharmaceutical Chemistry &gt; 10 Prodrugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-F60.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; F</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-F61.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Fosphenytoin Sodium</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; F</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E8E3E0R0D157.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Fosphenytoin</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; F</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>FOSPHENYTOIN SODIUM</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int880-fosphenytoin.htm">Fosphenytoin</a>).</p></div></div><div class="cF"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Fosphenytoin is a pro-drug of phenytoin</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">status epilepticus; seizures associated with neurosurgery or head injury; when phenytoin by mouth not possible</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="BNF:target-text: Phenytoin sodium cautions 4.8.2" href="PHP3046-phenytoin-sodium.htm#PHP3047">Phenytoin Sodium</a>; resuscitation facilities must be available; <strong>interactions:</strong> see <a title="target-block: Interactions in epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2899">Interactions</a> in section 4.8.1 and Appendix 1 (phenytoin)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">see <a title="BNF:target-text: Phenytoin Sodium contra-indications 4.8.2" href="PHP3046-phenytoin-sodium.htm#PHP3048">Phenytoin Sodium</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">consider 10–25% reduction in dose or infusion rate (except initial dose for status epilepticus)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">consider 10–25% reduction in dose or infusion rate (except initial dose for status epilepticus)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">see Phenytoin, <a title="BNF:monograph: PHENYTOIN" href="PHP2958-phenytoin.htm">section 4.8.1</a>, and <a title="BNF:target-block: Pregnancy and breast-feeding in epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2903">Pregnancy</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">see <a title="BNF:target-block: breast-feeding control of epilepsy" href="PHP2898-control-of-the-epilepsies.htm#PHP2904">Breast-feeding</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">see <a title="BNF:target-block: Phenytoin side-effects" href="PHP3046-phenytoin-sodium.htm#PHP3049">Phenytoin Sodium</a>; also dry mouth, taste disturbance, vasodilatation, asthenia, dysarthria, euphoria, incoordination, chills, visual disturbances, tinnitus, pruritus, ecchymosis; <em>less commonly</em> hypoaesthesia, increased or decreased reflexes, stupor, muscle weakness, muscle spasm, pain, hypoacusis; <em>also reported</em> extrapyramidal disorder, twitching, confusion, hyperglycaemia</p></div> <div class="cG"><div class="cE"><h3 class="cT">Important</h3> <p class="cT">Intravenous infusion of fosphenytoin has been associated with severe cardiovascular reactions including asystole, ventricular fibrillation, and cardiac arrest. Hypotension, bradycardia, and heart block have also been reported. The following are recommended:</p></div></div> <div class="cG"><ul><li><p>monitor heart rate, blood pressure, and respiratory function for duration of infusion;</p> </li><li><p>observe patient for at least 30 minutes after infusion;</p> </li><li><p>if hypotension occurs, reduce infusion rate or discontinue;</p> </li><li><p>reduce dose or infusion rate in elderly, and in renal or hepatic impairment.</p> </li></ul></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><div class="cI"><h3 class="cT">Note</h3> <p>Prescriptions for fosphenytoin sodium should state the dose in terms of phenytoin sodium equivalent (PE); fosphenytoin sodium 1.5 mg ≡ phenytoin sodium 1 mg</p> </div><ul>  <li><p>Status epilepticus, <span class="cK">by intravenous infusion</span> (at a rate of 100–150 mg(PE)/minute), initially 20 mg(PE)/kg then <span class="cK">by intravenous infusion</span> (at a rate of 50–100 mg(PE)/minute), 4–5 mg(PE)/kg daily in 1–2 divided doses, dose adjusted according to response and trough plasma-phenytoin concentration</p> <p><span class="cP">child</span> 5 years and over, <span class="cK">by intravenous infusion</span> (at a rate of 2–3 mg(PE)/kg/minute), initially 20 mg(PE)/kg then <span class="cK">by intravenous infusion</span> (at a rate of 1–2 mg(PE)/kg/minute), 4–5 mg(PE)/kg daily in 1–4 divided doses, dose adjusted according to response and trough plasma-phenytoin concentration</p> </li> <li><p>Prophylaxis or treatment of seizures associated with neurosurgery or head injury, <span class="cK">by intramuscular injection</span><em> or </em><span class="cK">by intravenous infusion</span> (at a rate of 50–100 mg(PE)/minute), initially 10–15 mg(PE)/kg then <span class="cK">by intramuscular injection</span><em> or </em><span class="cK">by intravenous infusion</span> (at a rate of 50–100 mg(PE)/minute), 4–5 mg(PE)/kg daily (in 1–2 divided doses), dose adjusted according to response and trough plasma-phenytoin concentration</p> <p><span class="cP">child</span> 5 years and over, <span class="cK">by intravenous infusion</span> (at a rate of 1–2 mg(PE)/kg/minute), initially 10–15 mg(PE)/kg then 4–5 mg(PE)/kg daily in 1–4 divided doses, dose adjusted according to response and trough plasma-phenytoin concentration</p> </li> <li><p>Temporary substitution for oral phenytoin, <span class="cK">by intramuscular injection</span><em> or </em><span class="cK">by intravenous infusion</span> (at a rate of 50–100 mg(PE)/minute), same dose and dosing frequency as oral phenytoin therapy; <span class="cP">child</span> 5 years and over, <span class="cK">by intravenous infusion</span> (at a rate of 1–2 mg(PE)/kg/minute, max. 100 mg(PE)/minute), same dose and dosing frequency as oral phenytoin therapy</p></li>   </ul><div class="cF"><div class="cE"><h3 class="cT">Note</h3> <p class="cT"><span class="cP">elderly</span> consider 10–25% reduction in dose or infusion rate</p></div></div><div class="cF"><div class="cE"><h3 class="cT">Note</h3> <p class="cT">Fosphenytoin sodium doses in BNF may differ from those in product literature</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP3034-pro-epanutin" style="margin: 0 0 0 20px;"><h1 class="title">Pro-Epanutin® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10287">Pfizer</a>)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Injection</strong>, fosphenytoin sodium 75 mg/mL (equivalent to phenytoin sodium 50 mg/mL), net price 10-mL vial = £40.00 </p><p class="cR"><span class="cAD">Electrolytes </span>phosphate 3.7 micromol/mg fosphenytoin sodium (phosphate 5.6 micromol/mg phenytoin sodium)</p></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3029-diazepam.htm">Previous: DIAZEPAM</a> | <a class="top" href="PHP3034-pro-epanutin.htm#">Top</a> | <a accesskey="]" href="PHP3035-lorazepam.htm">Next: LORAZEPAM</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>